In addition to landing on the IBD 50 list of growth stocks to watch. Guardant Health (GH) has also earned a spot on the Investor's Business Daily Leaderboard. And a recent approval of its Guardant360 CDx by the U.S.
Food and Drug Administration have shares of the precision oncology firm testing a buy zone. Earlier this month, the FDA approved…
Extract — continue reading at the source.
Related stories
Uranium Stocks Are Rallying. Why NXE Got Initiated At Overweight.
Paramount Moves Closer to Clearing a Major Antitrust Hurdle. Here’s How That Impacts Its Warner Bros. Discovery Acquisition.
Behind the Ticker: Crossmark's Values-Based ETFs
Down 53%, Should You Still Buy CoreWeave's (CRWV) Stock?
Paramount settles lawsuit with US states, helping clear way for $110bn merger with Warner Bros
Signal Says This Software Stock Could Soon Break Out